RI

RV Invest

Europe, Baden-Wurttemberg, Germany, Ravensburg

Description

RV Invest early and stand alongside founders and researchers to bring outstanding ideas to the market.

Investor Profile

RV Invest has backed more than 4 startups, with 3 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed rounds (top funding stages).
  • Majority of deals are located in Sweden, United States, The Netherlands.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (75%)
  • Seed (25%)

Country Focus

  • Sweden (25%)
  • United States (25%)
  • The Netherlands (25%)
  • Germany (25%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does RV Invest frequently co-invest with?

Eli Lilly & Company Foundation
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
BV
Europe, Luxembourg, Belgium, Luxembourg
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

What are some of recent deals done by RV Invest?

Valink Therapeutics

London, England, United Kingdom

Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.

Health CareTherapeuticsWellness
SeedOct 20, 2025
Amount Raised: $11,800,000
Akribion Genomics

Zwingenberg, Hessen, Germany

Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.

BiotechnologyHealth CareOncology
SeedFeb 4, 2025
Amount Raised: $8,251,353
Alesta Therapeutics

Leiden, Zuid-Holland, The Netherlands

Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.

Biotechnology
Series AJan 8, 2025
Amount Raised: $67,301,858
Arda Therapeutics

San Francisco, California, United States

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

BiotechnologyHealth CareTherapeutics
Series AOct 1, 2024
Amount Raised: $43,000,000
Asgard Therapeutics

Lund, Skane Lan, Sweden

Asgard Therapeutics is a Biotechnology Company.

BiotechnologyTherapeutics
Series AMar 14, 2024
Amount Raised: $32,648,548